Trial intelligence / Profile preview

Randomised Controlled Trial of Intravitreal Avastin vs Observation in Diabetic Ischaemic Macular Oedema

2011-003304-20Phase 3Terminated

Sponsor
Moorfields Eye Hospital
Start
May 2012
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 3, randomised trial in diabetic macular edema (DME) comparing Intravitreal Avastin with Observation (2 arms). Primary endpoint: Stabilization of visual acuity. Started May 2012; status: terminated.

02

Drugs

bevacizumab
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on 2011-003304-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003304-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call